miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

Por Reis, Sabrina Thalita, Pontes-Junior, José, Antunes, Alberto Azoubel, Dall’Oglio, Marcos Francisco, Dip, Nelson, Passerotti, Carlo Camargo, Rossini, Guilherme Ayres, Morais, Denis Reis, Nesrallah, Adriano Joao, Piantino, Camila, Srougi, Miguel, Leite, Katia R
Publicado em 2012